Cosmo Bio Co., Ltd.'s market cap is currently ¥7.07B. The company's EPS TTM is ¥6.81; its P/E ratio is 27.46; and it has a dividend yield of 5.00%. Cosmo Bio Co., Ltd. is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
